Targeted Immune System Booster Removes Toxic Proteins in Mouse Model of Alzheimer’s Disease

Alzheimer’s disease experts at NYULMC and elsewhere are reporting success in specifically harnessing a mouse’s immune system to attack and remove the buildup of toxic proteins in the brain that are markers of the deadly neurodegenerative disease. In the journal Acta Neuropathologica Communications online, the researchers say the work advances the development of more effective clinical treatments for Alzheimer’s because their immune booster reduced both amyloid beta plaques and tau tangles. Thomas Wisniewski, MD, a professor at NYU Langone, serves as lead study investigator. Read more...


NYU Langone Medical Center to Lead Research to Develop Breath Test for Chronic Obstructive Pulmonary Disease

NYU Langone Medical Center will lead a new clinical initiative -- funded by a $225,000 grant from The National Institutes of Health -- to determine a breath test’s effectiveness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstructive pulmonary disease (COPD). The study will employ patented technology developed by Menssana Research, a leading developer of advanced new breath tests for early detection of a wide variety of illnesses and diseases, and the principal recipient of the NIH grant. Read more...